These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H, Hashizume M, Masuda Y, Fujitani B, Hosoki K. Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [Abstract] [Full Text] [Related]
10. Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke. Gelmers HJ. Am J Cardiol; 1985 Jan 25; 55(3):144B-148B. PubMed ID: 2578724 [Abstract] [Full Text] [Related]
12. Effect of the calcium antagonist nimodipine on contractile responses of isolated canine basilar arteries induced by serotonin, prostaglandin F2 alpha, thrombin, and whole blood. White RP, Cunningham MP, Robertson JT. Neurosurgery; 1982 Mar 25; 10(3):344-8. PubMed ID: 6951113 [Abstract] [Full Text] [Related]
13. Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral ischemia in the dog. Milde LN, Milde JH, Michenfelder JD. J Cereb Blood Flow Metab; 1986 Jun 25; 6(3):332-7. PubMed ID: 3086330 [Abstract] [Full Text] [Related]